Filed Under: ,
Tickers in this Article: MDT
Medtronic (NYSE:MDT) announced its results for the most recent quarter on August 21, 2012. Medtronic provides products and therapies for medical professionals.

Earnings are perhaps the single most studied number in a company's financial statements because they show a company's profitability. SEE: How To Decode A Company's Earnings Reports

The Numbers: Medtronic's EPS fell in line with analyst expectations of 85 cents per share while revenue of $4.01 billion missed estimates of $4.23 billion. Revenue climbed 1.6% from the same period last year. Medtronic's profit rose 5.2% from last year's figures to $864 million during the first quarter. Last quarter marked the third in a row of rising net income.

Management Quote: "We delivered another quarter of improving revenue growth in a dynamic healthcare environment," said Omar Ishrak, Medtronic chairman and chief executive officer. "Once again, our growth was broad-based across businesses and geographies and reflects the positive impact of well-executed product launches and stabilizing end-markets."

A Look Back: Net income has increased 17.4% year-over-year on average across the last five quarters. The biggest gain came in the second quarter of the last fiscal year, when income climbed 53.9% from the year-earlier quarter.

Looking Ahead: Analysts appear increasingly optimistic about the company's results for the next quarter. The average estimate for the second quarter has moved up from 89 cents a share to 90 cents over the last 60 days. Increasing earnings estimate is a positive sign about the company and it typically leads a increase in the stock price. For the fiscal year, the average estimate has been unchanged at $3.66 a share.

comments powered by Disqus

Trading Center